NMI spin-off develops theranostics - 02/12/2024 immuneAdvice develops diagnostics to predict the efficacy of immunotherapies Certain types of cancer are already being effectively treated using immunotherapies, though success rates can vary significantly between patients. Researchers from the Natural and Medical Sciences Institute (NMI) in Reutlingen, along with colleagues at the University of Tübingen, are working on a diagnostic approach to accompany therapy, which would rapidly assess whether the treatment is effective or requires adjustment. https://www.gesundheitsindustrie-bw.de/en/article/news/immuneadvice-develops-diagnostics-predict-efficacy-immunotherapies
Press release - 28/11/2024 Molecular biology: New interdisciplinary Research Training Group investigates cellular regulation Cell division, cell differentiation, cell repair and cell death play fundamental roles in the human organism, its development, health and reproduction. Cellular transformation processes are governed by two regulatory mechanisms: chromatin modifications and cell signaling networks. The EpiSignal Research Training Group sheds light on the hitherto little-researched interplay between these two complex systems.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-biology-new-interdisciplinary-research-training-group-investigates-cellular-regulation
Vicinity Bio: Optimisation of cancer diagnostics - 27/11/2024 Comprehensive histological diagnostics through high-dimensional imaging and artificial intelligence Microscopic examination of tissue samples is essential, particularly in tumour diagnostics. The Tübingen-based company Vicinity Bio leverages cutting-edge imaging technologies combined with machine learning to generate comprehensive datasets of individual cells from tissue sections. This approach not only helps identify more targeted therapies but also enhances our understanding of cellular functions and processes within tissues and tumours.https://www.gesundheitsindustrie-bw.de/en/article/news/Comprehensive-histological-diagnostics-through-high-dimensional-imaging-and-artificial-intelligence
Press release - 26/11/2024 Cellular “power plants” control inflammation Researchers at the Medical Center – University of Freiburg and the University’s CIBSS Cluster of Excellence discover how mitochondria not only produce energy but also influence inflammation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cellular-power-plants-control-inflammation
Press release - 25/11/2024 Chromosomal chaos promotes therapy resistance in leukemia cells and opens up new treatment approaches Chromosomal instability plays a role in the progression of cancer: it shapes the properties of tumor cells and drives the development of therapy resistance. Scientists from the German Cancer Research Center (DKFZ), the Heidelberg Stem Cell Institute HI-STEM* and the European Molecular Biology Laboratory (EMBL) used state-of-the-art single-cell analysis methods to analyze the cellular heterogeneity of a specific form of acute myeloid leukemia. https://www.gesundheitsindustrie-bw.de/en/article/press-release/chromosomal-chaos-promotes-therapy-resistance-leukemia-cells-and-opens-new-treatment-approaches
Press release - 20/11/2024 Millions in federal funding: customized 3D printing for patients in oral and maxillofacial surgery The German Federal Ministry of Education and Research (BMBF) is currently funding a project at the Department of Oral and Maxillofacial Surgery at Heidelberg University Hospital with around 1.2 million euros. The aim is to use 3D printing technology to produce individualized implants directly in the clinic, thus enabling faster, more efficient and more precise patient-specific care. To this end, the UKHD is working with an industrial partner.https://www.gesundheitsindustrie-bw.de/en/article/press-release/millions-federal-funding-customized-3d-printing-patients-oral-and-maxillofacial-surgery
Press release - 20/11/2024 Research team develops novel biomimetic speaking valve technology The challenge: if conventional speaking valves are used improperly, dangerous overpressure can occur, which can cause serious complications and even death. In a collaboration at the University of Freiburg, researchers developed a speaking valve with an integrated pressure release valve and an acoustic warning signal, inspired by the trapping mechanism of the carnivorous bladderwort plant Utricularia vulgaris.https://www.gesundheitsindustrie-bw.de/en/article/press-release/forschungsteam-entwickelt-neuartige-biomimetische-sprechventil-technologie
Press release - 20/11/2024 New bioengineering approaches for the automated production of complex organoids The reproducible and precise production of complex organoid models to simulate human organ malfunctions is the focus of an interdisciplinary research project at Heidelberg University. A research team from the life and engineering sciences is looking to combine the engineering of molecular systems with machine learning and automated production methods. https://www.gesundheitsindustrie-bw.de/en/article/press-release/neue-ansaetze-des-bio-engineering-fuer-die-automatisierte-herstellung-komplexer-organoide
Greener NHS - 18/11/2024 National Health Service working towards climate neutrality The National Health Service (NHS) in the United Kingdom and Northern Ireland is taking steps to become more environmentally sustainable. The NHS has committed to the ambitious goal of achieving net zero carbon emissions by 2040, aiming to significantly reduce its climate impact in the coming years.https://www.gesundheitsindustrie-bw.de/en/article/news/national-health-service-working-towards-climate-neutrality
Event - 28/11/2024 Venture Capital Meet & Greet - Catalpa Ventures Online, Webinar https://www.gesundheitsindustrie-bw.de/en/event/venture-capital-meet-und-greet-catalpa-ventures
Press release - 15/11/2024 Selenium proteins as a possible new target for cancer research An important enzyme helps the body produce selenium proteins – this discovery could open up new strategies for treating cancer in children. This has been published by scientists from the University of Würzburg, the University Sao Paolo, the German Cancer Research Center (DKFZ) and the Heidelberg Stem Cell Institute HI-STEM*.https://www.gesundheitsindustrie-bw.de/en/article/press-release/selenium-proteins-possible-new-target-cancer-research
Press release - 15/11/2024 Patient association raises 10,000 euros for work on PURA syndrome - Donation for research into rare neuronal developmental disorder at Ulm University PURA syndrome is a rare developmental disorder of the brain for which there is currently no cure. The patient association PURA Syndrome Germany was founded last year. Since then, the affected families have been collecting donations with great dedication – and have decided to donate the majority of this money to research into the syndrome at Ulm University. https://www.gesundheitsindustrie-bw.de/en/article/press-release/patient-association-raises-10000-euros-work-pura-syndrome-donation-research-rare-neuronal-developmental-disorder-ulm-university
Press release - 14/11/2024 Novel method for fighting tumors Making existing cancer therapy more efficient while significantly reducing the side effects on healthy tissue - this is the aim of a project at Aalen University. It is being funded with one million euros from the Carl Zeiss Foundation. The biophysicist and his team are developing innovative nanoparticles made of gold. The particles use radiotherapy and chemotherapy simultaneously and kill the cancer cells in a targeted manner.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-method-for-fighting-tumors
Advancing quantum technology into real-world applications - 06/11/2024 QSens: BMBF future cluster brings quantum sensors of the future into medicine The BMBF-funded future cluster ‘QSens – Quantum Sensors of the Future’ is developing ultra-sensitive sensors that could open up new options in medicine, enabling faster drug research, more accurate diagnostics and improved rehabilitation. The universities of Stuttgart and Ulm are actively working with 17 industry partners to put these cutting-edge innovations to immediate practical use.https://www.gesundheitsindustrie-bw.de/en/article/news/qsens-bmbf-future-cluster-brings-quantum-sensors-future-medicine
Press release - 05/11/2024 How biomedical innovation improves preclinical research 3D tumor models, simulations of drug responses or plant stems used for testing heart stents: the 3R-BioMedicUS center at the University of Stuttgart is developing innovative biomedical approaches to improve preclinical studies, to be seen in the new video.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biomedical-innovation-improves-preclinical-research
Press release - 05/11/2024 Heidelberg scientist receives highly endowed EC synergy grant Heidelberg scientist Dr Venera Weinhardt has received an ERC Synergy Grant for a pioneering biomedical research project. The European Research Council (ERC) is granting this funding to advance soft X-ray microscopy. This imaging technique along with other innovations will be used to investigate the hepatitis E virus. https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-scientist-receives-highly-endowed-ec-synergy-grant
Press release - 30/10/2024 Diabetes switch in DNA: Non-coding region in the genome influences ONECUT1 gene They are underestimated genetic control elements: it is known that changes in the genome can trigger diabetes. But now researchers at the University Hospital Ulm and the INSERM Cochin Institute in Paris have shown that a previously under-researched region of the genome also plays a crucial role in the development of this disease. https://www.gesundheitsindustrie-bw.de/en/article/press-release/diabetes-switch-dna-non-coding-region-genome-influences-onecut1-gene
NMI project WOUNDSENS - 23/10/2024 Wound monitoring using sensory nanofibres Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres
Press release - 16/10/2024 Sensitive Arm Prostheses A quantum sensor that can register nerve impulses without contact opens up new possibilities in prosthetics. Researchers at Fraunhofer IPA are developing together with the industrial partner Q.ANT the prototype of one Prosthetic arm that is controlled by neural commands like healthy limbs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/sensitive-arm-prostheses
Sustainable medical technology - 10/10/2024 Rethinking plastics in medical technology Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology
Press release - 09/10/2024 Language model "UroBot“ surpasses the accuracy of experienced urologists Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. "UroBot" was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the accuracy of experienced urologists. https://www.gesundheitsindustrie-bw.de/en/article/press-release/language-model-urobot-surpasses-accuracy-experienced-urologists
Event - 13/11/2024 Networking Evening BW-UK | MEDICA 2024 MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: 08/11/2024, Messe https://www.gesundheitsindustrie-bw.de/en/event/networking-abend-bw-uk-medica-2024
Event - 13/11/2024 Networking Evening BW-UK | MEDICA 2024 MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: 08/11/2024, Messe https://www.bio-pro.de/en/events/networking-abend-bw-uk-medica-2024
Press release - 01/10/2024 Reporter Skin: In-vitro Skin Makes Cell Reaction to Test Substance Measurable in Real Time At the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, a three-dimensional skin model has now been set up for the first time that directly displays the skin's reaction to substances: The reporter skin. Thanks to the built-in reporter, the cellular response can be measured precisely and quickly – using a living model. https://www.gesundheitsindustrie-bw.de/en/article/press-release/reporter-skin-vitro-skin-makes-cell-reaction-test-substance-measurable-real-time
Transnational networking of innovation ecosystems HACK-IT-NET - enabling an alpine region Health And Care Knowledge and Innovation Transfer NETwork https://www.bio-pro.de/en/projects/current-projects/hack-it-net-enabling-alpine-region-health-and-care-knowledge-and-innovation-transfer-network
Press release - 25/09/2024 How do rare genetic variants affect health? AI provides more accurate predictions Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However in the case of genetic variants the influence on the presentation of certain pathological traits has been difficult to determine. Researchers have introduced an algorithm based on deep learning that can predict the effects of rare genetic variants. https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-do-rare-genetic-variants-affect-health-ai-provides-more-accurate-predictions
Chronic inflammatory bowel diseases - 25/09/2024 Proinflammatory regulatory T lymphocytes as a therapeutic target in Crohn's disease Chronic inflammatory bowel diseases are very stressful for those affected and increase the risk of bowel cancer. PD Dr. Robyn Laura Kosinsky from the Bosch Health Campus in Stuttgart, together with researchers from the USA, identified disfunctional regulatory T cells as important drivers of inflammation in Crohn's disease. They also found that with the help of an epigenetically active drug, it was possible to restore the cells’ original…https://www.gesundheitsindustrie-bw.de/en/article/news/proinflammatory-regulatory-t-lymphocytes-therapeutic-target-crohns-disease
Press release - 25/09/2024 How developmental signals can contribute to Genomic Mosaicism Certain developmental signals play a significant role in maintaining our genetic blueprints. They prevent alterations in the genome, known as mosaicism. The underlying biological mechanism helps the DNA to produce an identical copy of itself during cell division using the original genetic blueprint. However, it can also contribute to genomic mosaicism during nerve cell development.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-developmental-signals-can-contribute-genomic-mosaicism
Press release - 23/09/2024 Carl Zeiss Foundation supports early career research group for biohybrid neuroimplants Dr Simon Binder has been awarded a five-year, 1.5 million euro grant from the Carl Zeiss Foundation for his research into novel neuroimplants. Binder will establish the early career research group ‘Biohybrid Neuroimplants based on Soft Hydrogel Electrodes’ at the University of Freiburg. It is affiliated with the research institutions BrainLinks-BrainTools.https://www.gesundheitsindustrie-bw.de/en/article/press-release/carl-zeiss-foundation-supports-early-career-research-group-biohybrid-neuroimplants
Press release - 19/09/2024 Quality standards for looking into the tumor genome Personalized medicine with individually tailored therapies is becoming more a reality in cancer. This requires a look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out in Germany. The data is a prerequisite for integrating gene sequencing into routine care. https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-standards-looking-tumor-genome
Press release - 18/09/2024 Future cluster QSens starts the second round of funding In the “Cluster4Future” QSens of the Universities of Stuttgart and Ulm, scientists, companies and start-ups are researching quantum sensors with a wide range of potential applications. The Federal Ministry of Education and Research is funding QSens for a further three years as part of “Clusters4Future”.https://www.gesundheitsindustrie-bw.de/en/article/press-release/future-cluster-qsens-starts-second-round-funding
Press release - 17/09/2024 Five new cross-border doctoral networks at Universität Heidelberg Five transnational and cross-institutional doctoral networks at Heidelberg University are being funded as part of the “Marie Skłodowska-Curie Actions”. They work together on current scientific topics with high innovation potential. Ruperto Carola coordinates an MSCA Doctoral Network on artificial intelligence in physics, two networks in medicine, life sciences and engineering. https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-new-cross-border-doctoral-networks-universitat-heidelberg
Press release - 12/09/2024 Power-to-vitamins: microbes produce folate from simple basic ingredients Biotechnology team at University of Tübingen obtains valuable byproduct in protein production. This could be a potential to the contribution of feeding a growing world population without livestock farming.https://www.gesundheitsindustrie-bw.de/en/article/press-release/power-vitamins-microbes-produce-folate-simple-basic-ingredients
Press release - 11/09/2024 Researchers combine the power of artificial intelligence and the wiring diagram of a brain to predict brain cell activity Scientists have long sought ways to simulate the neural networks in the brain with computers in order to understand how it works. Now, researchers have combined new measurements of the wiring diagrams of the fruit fly with artificial intelligence methods to build a neural network that can do what few thought possible: To predict the activity of individual neurons without making a single measurement in a living brain. https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-combine-power-artificial-intelligence-and-wiring-diagram-brain-predict-brain-cell-activity
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…https://www.gesundheitsindustrie-bw.de/en/article/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…https://www.bio-pro.de/en/information/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros
Press release - 09/09/2024 New Molecular Engineering Technique allows for complex Organoids A new molecular engineering technique can precisely influence the development of organoids. Microbeads made of specifically folded DNA are used to release growth factors or other signal molecules inside the tissue structures. This gives rise to considerably more complex organoids that imitate the respective tissues much better and have a more realistic cell mix than before. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-molecular-engineering-technique-allows-complex-organoids
Press release - 05/09/2024 Cohesion at the cellular level: flexible yet stable Research teams from the Universities of Konstanz and Potsdam are analyzing how proteins work together to enable our cells to both stick and move. The marker protein paxillin is at the centre of their interest.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cohesion-cellular-level-flexible-yet-stable
Press release - 04/09/2024 Epigenetic changes reprogram astrocytes into brain stem cells With mice, researchers showed that experimentally induced lack of blood flow in the brain epigenetically reprograms astrocytes into brain stem cells, which in turn can give rise to nerve progenitor cells. This discovery shows that astrocytes could potentially be used in regenerative medicine to replace damaged nerve cells.https://www.gesundheitsindustrie-bw.de/en/article/press-release/epigenetic-changes-reprogram-astrocytes-brain-stem-cells
Innovation for sustainable plastic packaging - 04/09/2024 Liquid Plug & Play: eco-designed plastic packaging – not just for ultrasound gel In the healthcare industry tons of consumables such as ultrasound gel go to waste because packaging can’t be completely emptied. An invention called Liquid Plug & Play could offer a solution for the future. This innovation, which consists of a reusable outer shell and a disposable product pouch for viscous substances, can be completely emptied. It also prevents cross-contamination and offers many other benefits.https://www.gesundheitsindustrie-bw.de/en/article/news/liquid-plug-und-play-eco-designed-plastic-packaging-not-just-ultrasound-gel
Press release - 03/09/2024 NMR Spectroscopy: A Faster Way to Determine the “Sense of Rotation” of Molecules Researchers of Karlsruhe Institute of Technology (KIT) and Voxalytic GmbH developed a new method that allows, for the first time, to elucidate the chiral structure of molecules – the exact spatial arrangement of the atoms – by nuclear magnetic resonance (NMR) spectroscopy. This important step in the development of new drugs used to be a time-consuming process until now. https://www.gesundheitsindustrie-bw.de/en/article/press-release/nmr-spectroscopy-faster-way-determine-sense-rotation-molecules
Event - 06/11/2024 The TechMed Event 2024 TechMed Centre , Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/techmed-event-2024
Event - 05/11/2024 MedTech Twente Week: Explore & Connect fact-finding trip Enschede, Netherlands , Fact-finding trip https://www.gesundheitsindustrie-bw.de/en/event/medtech-twente-week-explore-und-connect-fact-finding-trip
Pipetting robot for academic research - 28/08/2024 goodBot GmbH: a third arm for researchers Repetitive tasks that researchers have to conduct in the lab tend to be tiring and often lead to errors. Precise pipetting is crucial for achieving reproducible results. Automation is underrepresented in research labs and existing pipetting robots are unsuitable for scientists. This is why Dr. Julius Wiener, Tobias Zundel and Oliver Brunner decided to found the company goodBot GmbH and develop a pipetting robot tailored to academic research.https://www.gesundheitsindustrie-bw.de/en/article/news/goodbot-gmbh-third-arm-researchers
Press release - 26/08/2024 Synthetic Immunology: Approaching a Turning Point in the Treatment and Prevention of Disease Synthetic immunology is the topic of an article in the “Perspectives” section of the journal “Nature Nanotechnology”. Herein, Heidelberg researchers describe a so-called bottom-up approach that uses the toolbox of nanotechnology and synthetic biology to construct systems from molecular building blocks and specifically equip them with immune functions. https://www.gesundheitsindustrie-bw.de/en/article/press-release/synthetic-immunology-approaching-turning-point-treatment-and-prevention-disease
Press release - 22/08/2024 Validated targets for personalized cancer immunotherapy Knowledge of the target structures for the immune cells is a basic prerequisite for the development of personalized cancer immunotherapies. Scientists from the German Cancer Research Center and the NCT Heidelberg are publishing a sensitive method based on mass spectroscopy to identify such tumor-specific "neoepitopes". The analytical method is designed to detect these low abundance protein fragments and requires minimal amounts of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/validated-targets-personalized-cancer-immunotherapy
Press release - 21/08/2024 A molecular control hub maintains order How are proteins in our cells modified while they are still being synthesized? An international team of researchers from the University of Konstanz, Caltech, and ETH Zurich has deciphered the molecular mechanism of this vital process. https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-control-hub-maintains-order
Event - 01/10/2024 Lunch & Learn: BW-UK Health Industry Procurement - Building Bridges for Better Healthcare Online, Registration deadline: 30/09/2024, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/lunch-und-learn-bw-uk-health-industry-procurement-building-bridges-better-healthcare
Event - 01/10/2024 Lunch & Learn: BW-UK Health Industry Procurement - Building Bridges for Better Healthcare Online, Registration deadline: 30/09/2024, Informationsveranstaltung https://www.bio-pro.de/en/events/past-events/lunch-und-learn-bw-uk-health-industry-procurement-building-bridges-better-healthcare
Event - 11/11/2024 - 15/11/2024 DigiHealthDay 2024 Deggendorf, Germany, Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/digihealthday-2024